Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella
eLife · 2025
DOI: 10.7554/elife.99130 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Yajun Zhai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China. Hauptthemen laut MEDLINE: Colistin, Anti-Bacterial Agents, Artesunate, Edetic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Discovering new strategies to combat the multidrug-resistant bacteria constitutes a major medical challenge of our time. Previously, artesunate (AS) has been reported to exert antibacterial enhancement activity in combination with β-lactam antibiotics via inhibition of the efflux pump AcrB. However, combination of AS and colistin (COL) revealed a weak synergistic effect against a limited number of strains, and few studies have further explored its possible mechanism of synergistic action. In this article, we found that AS and EDTA could strikingly enhance the antibacterial effects of COL against mcr-1 - and mcr-1 + Salmonella strains either in vitro or in vivo, when used in triple combination. The excellent bacteriostatic effect was primarily related to the increased cell membrane damage, accumulation of toxic compounds and inhibition of MCR-1. The potential binding sites of AS to MCR-1 (THR283, SER284, and TYR287) were critical for its inhibition of MCR-1 activity. Additionally, we also demonstrated that the CheA of chemosensory system and virulence-related protein SpvD were critical for the bacteriostatic synergistic effects of the triple combination. Selectively targeting CheA, SpvD, or MCR using the natural compound AS could be further investigated as an attractive strategy for the treatment of Salmonella infection. Collectively, our work opens new avenues toward the potentiation of COL and reveals an alternative drug combination strategy to overcome COL-resistant bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
ORCID-Profile: Yajun Zhai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhai, Y., Liu, P., Hu, X., Fan, C., Cui, X., He, Q., He, D., Ma, X., & Hu, G. (2025). Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella. eLife. https://doi.org/10.7554/elife.99130
Vancouver
Zhai Y, Liu P, Hu X, Fan C, Cui X, He Q, et al. Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella. eLife. 2025. doi:10.7554/elife.99130
BibTeX
@article{Zhai2025,
author = {Zhai, Yajun and Liu, Peiyi and Hu, Xueqin and Fan, Changjian and Cui, Xiaodie and He, Qibiao and He, Dandan and Ma, Xiaoyuan and Hu, Gongzheng},
title = {Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.99130}
}
EUVIMED